America's Best Contacts & Eyeglasses (EYE) Narx-foyda multiplikatori

America's Best Contacts & Eyeglasses (EYE) korporativ emblemasi va logotipi

National Vision Holdings (EYE) oftalmologiyada barqaror standartlarni joriy qilmoqda, shu bilan birga uning yetuk ko'rishni tuzatish mahsulotlari inflyatsiyaga chidamli bo'lib qolmoqda. Kompaniyaning konsolidatsiyalangan P/E ko'rsatkichi 22.40 joriy metrika darajasini aks ettirib, narx va foyda orasidagi farqni baholashga yordam beradi. Budjetli optika segmenti kontrsikllilikni ta'minlab, iqtisodiy pasayish davrida xarajatlarga e'tiborli mijozlarni jalb qiladi.

EYE: National Vision Holdings, Inc. Narxning foydaga nisbati 04.07.2022 - 17.11.2026

National Vision Corp (EYE) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning jamlanma tahlili:National Vision Holdings
National Vision Holdings, Inc. asosiy tovari

National Vision Holdings (EYE) optik tarmog'ining kapital talab qiluvchi yangi do'konlar ochilishi orqali murakkab kengayishi sof foydaga bevosita ta'sir ko'rsatadi, bu esa ushbu koeffitsiyentning maxrajini belgilaydi. Bozor kapitalizatsiyasining yillik daromadga nisbati biznes qiymatini uning samaradorligiga nisbatan baholash imkonini beradi, P/E koeffitsiyenti dinamikasi esa moliyaviy hisobotlar e'lon qilingandan keyin bozorning aktivlarni qayta baholash tezligini aniq namoyish etadi.

Raqobatdosh kompaniyalar tahlili

Kapitalizatsiyaning foydaga nisbati hcahealthcare.com HCA|Narxning foydaga nisbati Tenet Healthcare (THC)|Fresenius Medical Care - Narx-foyda multiplikatori|Narxning foydaga nisbati Solventum SOLV|Bozor narxining sof foydaga nisbati EHC (Encompass Health)|UHS: Narx-foyda koeffitsiyenti|DVA (DaVita) - Narx-foyda multiplikatori|RadNet Corp (RDNT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Option Care Corp (OPCH)|Narx-foyda koeffitsiyenti SGRY|PINC: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Progyny Corp (PGNY)|Ardent Health Partners - Narx-foyda multiplikatori|P/E multiplikatori SEM (Select Medical Inc.)|Kompaniya qiymatining sof foydaga nisbati ASTH|MD - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati USPH (U.S. Physical Therapy, Inc.)|PNTG: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Organogenesis (ORGO)|NUTX (Nutex Health Corp) - P/E multiplikatori|P/E multiplikatori Auna Health|P/E multiplikatori SBC|Biznesning o‘zini qoplash muddati evolus.com|Community Health Systems, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati SKIN (beautyhealth.com)|MDWD: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati BTMD|JYNT: P/E multiplikatori|Narx-foyda multiplikatori DCGO|PIII (P3 Health Partners Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Gain Therapeutics, Inc. GANX|Narx-foyda koeffitsiyenti EUDA (EUDA Health Holdings)|Narxning foydaga nisbati BMGL (Basel Medical Group Limited)|CollPlant Biotechnologies Ltd. - Narx-foyda koeffitsiyenti|CUPR: Narx-foyda multiplikatori|CCM: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AMS (American Shared Hospital Services)|MRM: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalon GloboCare Corp (ALBT)|Narxning foydaga nisbati DIH Holding|XAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NIVF|P/E multiplikatori ATI Physical Therapy Inc. (ATIP)|P/E multiplikatori CMAX (caremax.com)|Bozor narxining sof foydaga nisbati KDLY (Kindly Health)|MODV - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati novointegrated.com|SunLink Health Systems (SSY) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti IMAC Holdings Inc